128 related articles for article (PubMed ID: 10204690)
1. Identification of a domain affecting agonist potency of meta-chlorophenylbiguanide in 5-HT3 receptors.
Mochizuki S; Miyake A; Furuichi K
Eur J Pharmacol; 1999 Mar; 369(1):125-32. PubMed ID: 10204690
[TBL] [Abstract][Full Text] [Related]
2. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
Niemeyer MI; Lummis SC
Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig.
Lankiewicz S; Lobitz N; Wetzel CH; Rupprecht R; Gisselmann G; Hatt H
Mol Pharmacol; 1998 Feb; 53(2):202-12. PubMed ID: 9463477
[TBL] [Abstract][Full Text] [Related]
4. Cloning, expression, and characterization of ferret 5-HT(3) receptor subunit.
Mochizuki S; Watanabe T; Miyake A; Saito M; Furuichi K
Eur J Pharmacol; 2000 Jul; 399(2-3):97-106. PubMed ID: 10884508
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.
Jensen TN; Nielsen J; Frederiksen K; Ebert B
Eur J Pharmacol; 2006 May; 538(1-3):23-31. PubMed ID: 16647053
[TBL] [Abstract][Full Text] [Related]
6. Native serotonin 5-HT3 receptors expressed in Xenopus oocytes differ from homopentameric 5-HT3 receptors.
van Hooft JA; Kreikamp AP; Vijverberg HP
J Neurochem; 1997 Sep; 69(3):1318-21. PubMed ID: 9282959
[TBL] [Abstract][Full Text] [Related]
7. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
[TBL] [Abstract][Full Text] [Related]
8. The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.
Suryanarayanan A; Joshi PR; Bikádi Z; Mani M; Kulkarni TR; Gaines C; Schulte MK
Biochemistry; 2005 Jun; 44(25):9140-9. PubMed ID: 15966738
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of a rat 5-hydroxytryptamine type3 receptor subunit (r5-HT3A(b)) expressed in Xenopus laevis oocytes.
Mair ID; Lambert JJ; Yang J; Dempster J; Peters JA
Br J Pharmacol; 1998 Aug; 124(8):1667-74. PubMed ID: 9756382
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons.
Koyama S; Matsumoto N; Kubo C; Akaike N
J Physiol; 2000 Dec; 529 Pt 2(Pt 2):373-83. PubMed ID: 11101647
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells.
Bartrup JT; Newberry NR
J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467
[TBL] [Abstract][Full Text] [Related]
12. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes.
Oz M; Zhang L; Morales M
Synapse; 2002 Dec; 46(3):150-6. PubMed ID: 12325042
[TBL] [Abstract][Full Text] [Related]
13. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
Steward LJ; West KE; Kilpatrick GJ; Barnes NM
Eur J Pharmacol; 1993 Oct; 243(1):13-8. PubMed ID: 8253120
[TBL] [Abstract][Full Text] [Related]
14. Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells.
Lummis SC; Sepúlveda MI; Kilpatrick GJ; Baker J
Eur J Pharmacol; 1993 Oct; 243(1):7-11. PubMed ID: 8253126
[TBL] [Abstract][Full Text] [Related]
15. 5-HT3-like receptors in the rat medial prefrontal cortex: further pharmacological characterization.
Edwards E; Hampton E; Ashby CR; Zhang J; Wang RY
Brain Res; 1996 Sep; 733(1):21-30. PubMed ID: 8891244
[TBL] [Abstract][Full Text] [Related]
16. Selection of distinct conformational states of the 5-HT3 receptor by full and partial agonists.
van Hooft JA; Vijverberg HP
Br J Pharmacol; 1996 Mar; 117(5):839-46. PubMed ID: 8851499
[TBL] [Abstract][Full Text] [Related]
17. Introduction of the 5-HT3B subunit alters the functional properties of 5-HT3 receptors native to neuroblastoma cells.
Stewart A; Davies PA; Kirkness EF; Safa P; Hales TG
Neuropharmacology; 2003 Feb; 44(2):214-23. PubMed ID: 12623220
[TBL] [Abstract][Full Text] [Related]
18. The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E-115 neuroblastoma cells.
Sepúlveda MI; Lummis SC; Martin IL
Br J Pharmacol; 1991 Oct; 104(2):536-40. PubMed ID: 1797317
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the apparent splice variants of the murine 5-HT3 R-A subunit expressed in Xenopus laevis oocytes.
Downie DL; Hope AG; Lambert JJ; Peters JA; Blackburn TP; Jones BJ
Neuropharmacology; 1994; 33(3-4):473-82. PubMed ID: 7984286
[TBL] [Abstract][Full Text] [Related]
20. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
